On the contrary, whilst percentage change values were not provided, a slight decrease in TH BMD, although non-significant, was observed with ZA compared to a highly significant increase with denosumab [−0.001 g/cm 2 vs. 0.019 g/cm 2 [ 48 ]].
← all excerpts
Effectiveness and safety of bone protective interventions to mitigate bone loss and skeletal fractures experienced by patients with non-metastatic breast cancer: a systematic review and meta-analysis.
1
—
—